Abeona Therapeutics (ABEO) Non-Current Deffered Revenue (2010 - 2026)

Abeona Therapeutics (ABEO) recorded quarterly Non-Current Deffered Revenue of $425000.0 in Q1 2026, down 86.12% quarter-over-quarter from $3.1 million in Q4 2017.

Abeona Therapeutics (ABEO) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends

Abeona Therapeutics' Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $425000.0 for Q1 2026.

  • In Q1 2026, Non-Current Deffered Revenue changed N/A year-over-year to $425000.0; the TTM figure through Mar 2026 stood at $425000.0 (changed N/A YoY), while the FY2017 annual figure was $3.1 million, down 16.46% from the prior year.
  • Non-Current Deffered Revenue was $425000.0 for Q1 2026 at Abeona Therapeutics, down from $3.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $425000.0 in Q1 2026 to a low of $425000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Abeona Therapeutics 309.15 Mn 140.88 Mn 6.02 Mn 425,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 425,000.00
Dec 31, 2017 3.06 Mn
Sep 30, 2017 3.21 Mn
Jun 30, 2017 3.36 Mn
Mar 31, 2017 3.51 Mn
Dec 31, 2016 3.66 Mn
Sep 30, 2016 3.81 Mn
Jun 30, 2016 3.97 Mn
Mar 31, 2016 4.12 Mn
Dec 31, 2015 4.27 Mn
Sep 30, 2015 4.42 Mn
Jun 30, 2015 4.57 Mn
Mar 31, 2015 4.72 Mn
Dec 31, 2014 4.87 Mn
Sep 30, 2014 5.02 Mn
Jun 30, 2014 5.17 Mn
Mar 31, 2014 5.32 Mn
Dec 31, 2013 5.24 Mn
Sep 30, 2013 5.39 Mn
Jun 30, 2013 5.53 Mn